Skip to main content

What the FDA labels say about taking them together

Phenobarbital and verapamil

Verapamil's FDA label of April 6, 2026 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name verapamil. The verapamil label: “Phenobarbital therapy may increase verapamil clearance.”

Check it at the source: the phenobarbital FDA label on DailyMed (effective August 27, 2026); the verapamil FDA label on DailyMed (effective April 6, 2026, Zydus Pharmaceuticals (USA) Inc.).

What does the phenobarbital label say about verapamil?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name verapamil in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

What does the verapamil label say about phenobarbital?

Verapamil label, drug interactions

Phenobarbital: Phenobarbital therapy may increase verapamil clearance.

Source: FDA drug label (Verapamil Hydrochloride, NDA020943), Wilshire Pharmaceuticals, Inc., effective November 27, 2024 (SPL set 5f665d08-e1e4-422a-88c2-d8834abf9e1a), via openFDA

Source: FDA drug label (Verapamil hydrochloride), Zydus Pharmaceuticals (USA) Inc., effective April 6, 2026 (SPL set e19ab8d8-dae5-489d-9805-7e7407bea06d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Phenobarbital generic labelers
43Verapamil generic labelers
PhenobarbitalVerapamil
Labeled forSeizures and epilepsyHigh blood pressure, Atrial fibrillation, Angina
Boxed warningNoNo
Pharmacy cost (NADAC)$0.213 per tablet 100 mg tablet$0.191 per tablet 180 mg tablet
Shortage nowA presentation being discontinuedA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?